ETI (3 months) was also reported to significantly decrease IL-6, as well as IL-18, IL-1β and TNF-α levels in CF serum and following stimulation of isolated PBMCs by lipopolysaccharide and ATP (n=19). This evidence concerns the gene IL1B and cystic fibrosis.